Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.
P/B ratio for Marpai, Inc. (MRAI)
P/B ratio as of 2023: -0.91
According to Marpai, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.91. At the end of 2022 the company had a P/B ratio of 2.38.
P/B ratio history for Marpai, Inc. from 2019 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | -0.91 |
| 2022 | 2.38 |
| 2021 | 2.99 |
| 2020 | -27.34 |
| 2019 | -109.47 |